{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:14:26Z","timestamp":1790291666910,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FDM202006011155"],"award-info":[{"award-number":["FDM202006011155"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>The complement system contributes to the progression of immunoglobulin A nephropathy (IgAN) and offers promising therapeutic targets currently under investigation. Identifying appropriate candidates for these treatments is now critical. Currently, complement activation in IgAN is assessed using immunostaining of kidney tissues, a method that lacks precision in differentiating ongoing and past complement activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Complement deposition was assessed in diagnostic kidney biopsies from 53 patients with primary IgAN and positive C3c staining. Immunohistochemistry was used to assess glomerular deposition of C4d and C5b-9, while immunofluorescence was employed for C3b\/iC3b and C1q. In situ detection of C3 and C5 convertase complexes from the classical\/lectin (C4b2b) and alternative (C3bBb) complement pathways was performed on paraffin-embedded kidney biopsies from 33 of these patients using a proximity ligation assay (Duolink\u00ae). Biopsies from patients with lupus nephritis and C3 glomerulopathy (C3G) served as positive controls. Convertase signals were quantified using QuPath\u00ae Software and correlated with MEST-C score, C5b-9 staining and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>C3bBb convertases were identified in 20\/33 C3c-positive (60.6%) patients, with a median positive area of 15.5 (3.4\u201324.8) \u2030 of the glomerular surface. C4b2b convertases were detected in 22\/33 (66.7%) patients, covering a median positive area of 8.3 (4.1\u201311.8) \u2030. Both convertases were present in 13\/33 (39.4%) patients, while 4\/33 (12.1%) patients had no convertases despite positive C3c staining. Double-negative patients had better renal survival (P\u00a0=\u00a0.0387). C3bBb-staining positive area significantly correlated with mesangial C5b-9 deposition intensity (P\u00a0=\u00a0.0011). Patients with MEST-C scores E1 and S1 showed greater C3bBb intensity at diagnosis (P\u00a0=\u00a0.0251 and P\u00a0=\u00a0.0004, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrates ongoing complement activation in 29\/33 (87.9%) C3c-positive IgAN patients. Notably, activation of the alternative pathway correlated with E1 and S1 lesions, C5b-9 deposition and poorer renal survival. In situ convertase detection may help identify patients most likely to benefit from complement-targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfaf200","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:12:19Z","timestamp":1759234339000},"page":"715-724","source":"Crossref","is-referenced-by-count":9,"title":["In situ assessment of glomerular C3\/C5 convertases indicates ongoing complement activation in IgA nephropathy"],"prefix":"10.1093","volume":"41","author":[{"given":"Augustin","family":"Obrecht","sequence":"first","affiliation":[{"name":"Strasbourg University Hospitals Department of Nephrology, Dialysis and Transplantation, , Strasbourg ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Sophie","family":"Meuleman","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Sorbonne Universit\u00e9, Inflammation, Complement and Cancer Team , Paris ,","place":["France"]},{"name":"University Hospital Federation (FHU) COMET , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Olagne","sequence":"additional","affiliation":[{"name":"Strasbourg University Hospitals Department of Nephrology, Dialysis and Transplantation, , Strasbourg ,","place":["France"]},{"name":"Strasbourg University Hospitals Department of Pathology, , Strasbourg ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Grunenwald","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Sorbonne Universit\u00e9, Inflammation, Complement and Cancer Team , Paris ,","place":["France"]},{"name":"University Hospital Federation (FHU) COMET , Paris ,","place":["France"]},{"name":"Poissy-Saint-Germain Intercommunal Hospital Center Department of Nephrology, , Poissy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Chauvet","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Sorbonne Universit\u00e9, Inflammation, Complement and Cancer Team , Paris ,","place":["France"]},{"name":"University Hospital Federation (FHU) COMET , Paris ,","place":["France"]},{"name":"Georges Pompidou European Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP) Department of Nephrology, , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-0324","authenticated-orcid":false,"given":"Lubka","family":"Roumenina","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Sorbonne Universit\u00e9, Inflammation, Complement and Cancer Team , Paris ,","place":["France"]},{"name":"University Hospital Federation (FHU) COMET , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Sorbonne Universit\u00e9, Inflammation, Complement and Cancer Team , Paris ,","place":["France"]},{"name":"University Hospital Federation (FHU) COMET , Paris ,","place":["France"]},{"name":"Georges Pompidou European Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP) Department of Biological Immunology, , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Caillard","sequence":"additional","affiliation":[{"name":"Strasbourg University Hospitals Department of Nephrology, Dialysis and Transplantation, , Strasbourg ,","place":["France"]},{"name":"UMR1109 \u2013 Molecular Immuno-Rheumatology, Centre de Recherche en Biom\u00e9decine de Strasbourg (CRBS), INSERM, University of Strasbourg , Strasbourg ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Duval","sequence":"additional","affiliation":[{"name":"Strasbourg University Hospitals Department of Nephrology, Dialysis and Transplantation, , Strasbourg ,","place":["France"]},{"name":"Centre de Recherche des Cordeliers, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Sorbonne Universit\u00e9, Inflammation, Complement and Cancer Team , Paris ,","place":["France"]},{"name":"UMR1109 \u2013 Molecular Immuno-Rheumatology, Centre de Recherche en Biom\u00e9decine de Strasbourg (CRBS), INSERM, University of Strasbourg , Strasbourg ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2026033111013984700_bib1","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/ndt\/gfad082","article-title":"The incidence and prevalence of IgA nephropathy in Europe","volume":"38","author":"Willey","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111013984700_bib2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.kint.2018.02.030","article-title":"Secondary IgA nephropathy","volume":"94","author":"Saha","year":"2018","journal-title":"Kidney Int"},{"key":"2026033111013984700_bib3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111013984700_bib4","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/ndt\/gfad140","article-title":"The complement system in IgAN: mechanistic context for therapeutic opportunities","volume":"38","author":"Duval","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111013984700_bib5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","article-title":"IgA nephropathy: an interesting autoimmune kidney disease","volume":"361","author":"Rajasekaran","year":"2021","journal-title":"Am J Med Sci"},{"key":"2026033111013984700_bib6","first-page":"117","article-title":"The origin and activities of IgA1-containing immune complexes in IgA nephropathy","volume":"7","author":"Knoppova","year":"2017","journal-title":"Front Immunol"},{"key":"2026033111013984700_bib7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"2026033111013984700_bib8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrneph.2017.67","article-title":"Updated Oxford Classification of IgA nephropathy: a new MEST-C score","volume":"13","author":"Markowitz","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026033111013984700_bib9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2014.63","article-title":"Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments","volume":"86","author":"Coppo","year":"2014","journal-title":"Kidney Int"},{"key":"2026033111013984700_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/pin.12442","article-title":"Validation study of Oxford Classification of IgA nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining: IgAN Oxford Classification validation","volume":"66","author":"\u015etefan","year":"2016","journal-title":"Pathol Int"},{"key":"2026033111013984700_bib11","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/ndt\/gfz009","article-title":"The Oxford Classification for immunoglobulin A nephropathy: a common language blurred by dissonant voices","volume":"34","author":"Maillard","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111013984700_bib12","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1681\/ASN.2007050526","article-title":"Remission of proteinuria improves prognosis in IgA nephropathy","volume":"18","author":"Reich","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026033111013984700_bib13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","article-title":"Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population","volume":"27","author":"Le","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111013984700_bib14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I\u2014molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015;","journal-title":"Front Immunol"},{"key":"2026033111013984700_bib15","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2215\/CJN.09100819","article-title":"Biomarkers to predict progression in IgA nephropathy","volume":"14","author":"Cheung","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111013984700_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.kint.2023.04.029","article-title":"IgA nephropathy: the lectin pathway and implications for targeted therapy","volume":"104","author":"Barratt","year":"2023","journal-title":"Kidney Int"},{"key":"2026033111013984700_bib17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/eji.1830170304","article-title":"Activation of the alternative pathway of complement by human serum IgA","volume":"17","author":"Hiemstra","year":"1987","journal-title":"Eur J Immunol"},{"key":"2026033111013984700_bib18","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"2026033111013984700_bib19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0272-6386(88)80022-2","article-title":"The immunohistology of IgA nephropathy","volume":"12","author":"Jennette","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"2026033111013984700_bib20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2215\/CJN.09710913","article-title":"Association of C4d deposition with clinical outcomes in IgA nephropathy","volume":"9","author":"Espinosa","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111013984700_bib21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00467-019-04445-x","article-title":"Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"35","author":"Dumont","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"2026033111013984700_bib22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ekir.2017.11.015","article-title":"Progressive IgA nephropathy is associated with low circulating Mannan-Binding Lectin\u2013Associated Serine Protease-3 (MASP-3) and increased Glomerular Factor H\u2013Related Protein-5 (FHR5) deposition","volume":"3","author":"Medjeral-Thomas","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2026033111013984700_bib23","doi-asserted-by":"publisher","first-page":"e1002765","DOI":"10.1371\/journal.pgen.1002765","article-title":"Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis","volume":"8","author":"Kiryluk","year":"2012","journal-title":"PLoS Genet"},{"key":"2026033111013984700_bib24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/imr.13147","article-title":"C3-dependent effector functions of complement","volume":"313","author":"Zarantonello","year":"2023","journal-title":"Immunol Rev"},{"key":"2026033111013984700_bib25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.ekir.2020.03.009","article-title":"In situ visualization of C3\/C5 convertases to differentiate complement activation","volume":"5","author":"Person","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026033111013984700_bib26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","article-title":"The classical pathway triggers pathogenic complement activation in membranous nephropathy","volume":"14","author":"Seifert","year":"2023","journal-title":"Nat Commun"},{"key":"2026033111013984700_bib27","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1681\/ASN.0000000000000373","article-title":"Complement terminal pathway activation and intrarenal immune response in C3 glomerulopathy","volume":"35","author":"Meuleman","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026033111013984700_bib28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2215\/CJN.09710913","article-title":"Association of C4d deposition with clinical outcomes in IgA nephropathy","volume":"9","author":"Espinosa","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111013984700_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2215\/CJN.02530317","article-title":"Mesangial C4d deposits in early IgA nephropathy","volume":"13","author":"Segarra","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111013984700_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/ndt\/gfz241","article-title":"Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy","volume":"36","author":"Trimarchi","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026033111013984700_bib31","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.xkme.2021.06.009","article-title":"Glomerular C4d deposition and kidney disease progression in IgA nephropathy: a systematic review and meta-analysis","volume":"3","author":"Jiang","year":"2021","journal-title":"Kidney Med"},{"key":"2026033111013984700_bib32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2215\/CJN.02530317","article-title":"Mesangial C4d deposits in early IgA nephropathy","volume":"13","author":"Segarra","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026033111013984700_bib33","first-page":"3299","article-title":"Prognostic value of glomerular C4d staining in patients with IgA nephritis","volume":"7","author":"Sahin","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"2026033111013984700_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ekir.2023.11.005","article-title":"Systematic review of the link between Oxford MEST-C Classification and complement activation in IgA nephropathy","volume":"9","author":"\u0218tefan","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026033111013984700_bib35","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2026033111013984700_bib36","doi-asserted-by":"publisher","first-page":"599974","DOI":"10.3389\/fimmu.2020.599974","article-title":"Deposition of the membrane attack complex in healthy and diseased human kidneys","volume":"11","author":"Koopman","year":"2021","journal-title":"Front Immunol"},{"key":"2026033111013984700_bib37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.1987.72","article-title":"Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis","volume":"31","author":"Rauterberg","year":"1987","journal-title":"Kidney Int"},{"key":"2026033111013984700_bib38","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/ndt\/10.7.1166","article-title":"The pathogenetic significance of C5b-9 in IgA nephropathy","volume":"10","author":"Alexopoulos","year":"1995","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf200\/64464522\/gfaf200.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/4\/715\/64464522\/gfaf200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/4\/715\/64464522\/gfaf200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:01:50Z","timestamp":1774969310000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/4\/715\/8270689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf200","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,10,1]]}}}